2.2 Eligibility criteria and relevant outcomes Studies which answered the most important question (regarding the efficacy and safety of subcutaneous semaglutide treatment on weight loss) and report the experiences of adults (age 18 years) with overweight or obese (BMI 25kg/m 2 ) who were prescribed semaglutide treatment for weight management in randomized controlled trials were included
JCGG conceived and designed microbial isolation and characterization studies and helped draft the manuscript
Emotional advantages, such as improved self-confidence, appear frequently in responses
Your GP can assess your eligibility and refer you to appropriate services, which may include dietary support, behavioural interventions, and pharmacotherapy
Antihyperglycemic effects aside, GLP-1 RAs reduce gastric emptying and suppress appetite centres in the hypothalamus, resulting in weight loss
Hidradenitis suppurativa: where we are and where we are going